StockData
Intellia Therapeutics, Inc. logo

Intellia Therapeutics, Inc. (NTLA) stock

NTLANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/307% above fair value
$9.77−0.01 (-0.10%)

Close on Nov 18, 2026Market cap $1.37BP/E –Yield –

Intellia Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Intellia Therapeutics's market cap was $1.60B on Nov 11, 2026, against $1.04B a year earlier. Over the last 5 years it ranged from $711.32M to $8.79B, with a median of $2.16B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.60B+53.5%
2025Dec 31, 2025$1.04B-12.3%
2024Dec 31, 2024$1.19B-56.3%
2023Dec 29, 2023$2.72B+1.7%
2022Dec 30, 2022$2.67B-69.6%
2021Dec 31, 2021$8.79B+174.8%
2020Dec 31, 2020$3.20B+346.0%
2019Dec 31, 2019$717.03M+21.1%
2018Dec 31, 2018$591.99M-14.6%
2017Dec 29, 2017$693.56M+47.0%
2016Dec 30, 2016$471.90M–

More Intellia Therapeutics figures

See a number that looks wrong?